In finance, the industry’s cornerstone companies don’t make a habit of dashing headlong to adopt bleeding-edge technologies. As in many conservative and regulated industries, leaders almost ...

Eastvale Roosevelt’s Brayden Burries and Ontario Christian’s Kaleena Smith headline the L.A. Times’ 2024-25 All-Star boys’ and girls’ basketball teams. Here’s complete coverage.

The measles outbreak in western Texas has reached 309 cases, surpassing last year's U.S. total of 285, according to new data. One unvaccinated 'school-aged' child has died, marking the first U.S ...

MILAN - Italy's education ministry on Friday instructed schools to ban the growing use of gender-neutral symbols, saying they were unclear and flouted the rules of Italian grammar. The move risks ...

The Philadelphia Phillies and Atlanta Braves are set for a Spring Training match on March 20, 2025, at CoolToday Park. Both teams, looking to finalize their lineups and build momentum, will ...

Beijing’s threat to stop a tycoon’s sale of his ports business has dealmakers wondering if they can still operate without political interference. By Alexandra Stevenson and Joy Dong Reporting ...

The US has imposed sanctions on two Chinese petrochemicals groups for allegedly importing Iranian crude oil, in the latest salvo of President Donald Trump’s “maximum pressure” campaign on ...

The famous saying, “Culture eats strategy for breakfast and transformation for lunch,” highlights the importance of company culture in achieving business success. Yet, even the best strategies ...

Disha Salian's father in a plea before the Bombay high court, demanded an FIR against Aaditya Thackeray and that the probe be transferred to the CBI Shiv Sena (UBT) leader Aaditya Thackeray on ...

SEALSQ Corp (NASDAQ: LAES) ("SEALSQ" or "Company"), a company that focuses on developing and selling Semiconductors, PKI, and Post-Quantum technology hardware and software products, today ...

– Favorable outcome from interim analysis of ongoing ALTO-300 Phase 2b MDD trial; topline results expected in mid-2026 – – Completed enrollment in ALTO-203 Phase 2 proof-of-concept MDD trial ...